Single-dose antibiotic prophylaxis in women undergoing elective caesarean section

Area of Science:

• Obstetrics and Gynecology
• Infectious Disease Prevention
• Surgical Prophylaxis

Background:

• Postoperative infectious morbidity is a significant concern following caesarean sections.
• Elective caesarean sections, while planned, still carry a risk of infection.
• Antibiotic prophylaxis is a common strategy to mitigate surgical site infections.

Purpose of the Study:

• To evaluate the effectiveness of a single intravenous dose of Augmentin for antibiotic prophylaxis.
• To assess the impact of Augmentin on infectious morbidity after elective caesarean sections.
• To compare outcomes between women receiving Augmentin and those receiving no prophylaxis.

Main Methods:

• Prospective, randomized, controlled trial involving 200 women undergoing elective caesarean section.
• Participants were randomly assigned to receive either 1.2 g Augmentin intravenously or no antibiotic treatment pre-operatively.
• Patient characteristics and operation variables were comparable between the two groups.

Main Results:

• The overall postoperative morbidity rate was significantly lower in the Augmentin group (19%) compared to the control group (38%) (p < 0.01).
• Incidence of wound sepsis was reduced from 13% in the control group to 3% in the Augmentin group (p < 0.01).
• Febrile morbidity decreased from 18% to 8% (p < 0.05), and hospital stay was shorter with Augmentin (p < 0.05).

Conclusions:

• A single-dose of prophylactic Augmentin is effective in reducing postoperative infectious morbidity following elective caesarean sections.
• This prophylactic regimen also leads to a shorter duration of hospital stay.
• Augmentin offers a beneficial and effective strategy for infection prevention in this patient population.